Masabumi Shibuya
Impact in
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
- Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research
Papers in
-
- Angiogenesis and VEGF in Cancer 108
- TGF-β signaling in diseases 14
- PI3K/AKT/mTOR signaling in cancer 10
- Oncology 48
- Lymphatic System and Diseases 25
- Co-authors
- Lena Claesson‐Welsh (7 shared papers)Hiroshi Ogawara (1 shared paper)Yuko Fukami (1 shared paper)Shizue Nakagawa (1 shared paper)Tetsu Akiyama (1 shared paper)Junko Ishida (1 shared paper)Shun‐ichi Watanabe (1 shared paper)Hiroyuki Takahashi (3 shared papers)
- Journals
- Journal of Biological Chemistry (15 papers)Biochemical and Biophysical Research Communications (10 papers)Proceedings of the National Academy of Sciences (8 papers)Cancer Research (8 papers)Blood (7 papers)
- Partner nations
- JapanUnited StatesSweden
In The Last Decade
Masabumi Shibuya
213 papers receiving 20.3k citations
Masabumi Shibuya's Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 3.3k
- Immunology and Allergy 966
- Oncology 4.3k
- Molecular Biology 11.5k
- Immunology 2.4k
Countries citing papers authored by Masabumi Shibuya
This map shows the geographic impact of Masabumi Shibuya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masabumi Shibuya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masabumi Shibuya more than expected).
Fields of papers citing papers by Masabumi Shibuya
This network shows the impact of papers produced by Masabumi Shibuya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masabumi Shibuya. The network helps show where Masabumi Shibuya may publish in the future.
Co-authors
The 25 scholars most cited alongside Masabumi Shibuya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 215 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genistein, a specific inhibitor of tyrosine-specific protein kinases. Hit paper breakdown → | 1987 | 3285 |
| 2 | Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. Hit paper breakdown → | 1994 | 1393 |
| 3 | Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis Hit paper breakdown → | 2005 | 852 |
| 4 | The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions Hit paper breakdown → | 2005 | 750 |
| 5 | MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis Hit paper breakdown → | 2002 | 706 |
| 6 | Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases Hit paper breakdown → | 2012 | 635 |
| 7 | Differential Roles of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Angiogenesis Hit paper breakdown → | 2006 | 506 |
| 8 | 1998 | 425 | |
| 9 | 2001 | 416 | |
| 10 | 2001 | 405 | |
| 11 | 2009 | 319 | |
| 12 | 1998 | 307 | |
| 13 | Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. | 1996 | 307 |
| 14 | 1998 | 279 | |
| 15 | Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. | 1996 | 255 |
| 16 | 2008 | 223 | |
| 17 | 1995 | 217 | |
| 18 | 1985 | 211 | |
| 19 | 2015 | 185 | |
| 20 | 2001 | 184 |
About Masabumi Shibuya
Masabumi Shibuya is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Cellular and Molecular Neuroscience, having authored 215 papers that have together received 20.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (108 papers), Lymphatic System and Diseases (25 papers), Cancer, Hypoxia, and Metabolism (24 papers), Axon Guidance and Neuronal Signaling (19 papers), Cell Adhesion Molecules Research (17 papers), TGF-β signaling in diseases (14 papers), Pregnancy and preeclampsia studies (10 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). The work is most often cited by research in Cancer Research (3.3k citations), Immunology and Allergy (966 citations), Oncology (4.3k citations), Molecular Biology (11.5k citations) and Immunology (2.4k citations). Masabumi Shibuya has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Lena Claesson‐Welsh, Hiroshi Ogawara, Yuko Fukami, Shizue Nakagawa, Tetsu Akiyama, Junko Ishida, Shun‐ichi Watanabe, Hiroyuki Takahashi, Johannes Waltenberger and Carl‐Henrik Heldin. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications, Proceedings of the National Academy of Sciences, Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.